These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8729171)
41. Mechanisms of fatty acid-induced inhibition of glucose uptake. Boden G; Chen X; Ruiz J; White JV; Rossetti L J Clin Invest; 1994 Jun; 93(6):2438-46. PubMed ID: 8200979 [TBL] [Abstract][Full Text] [Related]
42. Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds? Proietto J; Andrikopoulos S; Rosella G; Thorburn A Aust N Z J Med; 1995 Dec; 25(6):870-5. PubMed ID: 8770366 [TBL] [Abstract][Full Text] [Related]
43. Effect of insulin on glucose utilization in epitrochlearis muscle of rats with streptozocin-induced NIDDM. Karl IE; Gavin JR; Levy J Diabetes; 1990 Sep; 39(9):1106-15. PubMed ID: 2200730 [TBL] [Abstract][Full Text] [Related]
44. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680 [TBL] [Abstract][Full Text] [Related]
45. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Streeper RS; Henriksen EJ; Jacob S; Hokama JY; Fogt DL; Tritschler HJ Am J Physiol; 1997 Jul; 273(1 Pt 1):E185-91. PubMed ID: 9252495 [TBL] [Abstract][Full Text] [Related]
46. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus. Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832 [TBL] [Abstract][Full Text] [Related]
47. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Kim JK; Wi JK; Youn JH Diabetes; 1996 May; 45(5):651-8. PubMed ID: 8621018 [TBL] [Abstract][Full Text] [Related]
48. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961 [TBL] [Abstract][Full Text] [Related]
49. Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats. Park JY; Kim CH; Hong SK; Suh KI; Lee KU Am J Physiol; 1998 Aug; 275(2):E338-44. PubMed ID: 9688637 [TBL] [Abstract][Full Text] [Related]
50. Role of the glucosamine pathway in fat-induced insulin resistance. Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789 [TBL] [Abstract][Full Text] [Related]
51. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Henry RR; Abrams L; Nikoulina S; Ciaraldi TP Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000 [TBL] [Abstract][Full Text] [Related]
53. GLUT-4 content in plasma membrane of muscle from patients with non-insulin-dependent diabetes mellitus. Lund S; Vestergaard H; Andersen PH; Schmitz O; Gøtzsche LB; Pedersen O Am J Physiol; 1993 Dec; 265(6 Pt 1):E889-97. PubMed ID: 8279544 [TBL] [Abstract][Full Text] [Related]
54. Acute effects of graded alcohol intake on glucose, insulin and free fatty acid levels in non-insulin-dependent diabetic subjects. Christiansen C; Thomsen C; Rasmussen O; Glerup H; Berthelsen J; Hansen C; Orskov H; Hermansen K Eur J Clin Nutr; 1993 Sep; 47(9):648-52. PubMed ID: 8243430 [TBL] [Abstract][Full Text] [Related]
55. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Shah P; Vella A; Basu A; Basu R; Adkins A; Schwenk WF; Johnson CM; Nair KS; Jensen MD; Rizza RA Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736 [TBL] [Abstract][Full Text] [Related]
56. Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Roden M; Shulman GI Annu Rev Med; 1999; 50():277-90. PubMed ID: 10073278 [TBL] [Abstract][Full Text] [Related]
57. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. Kashyap SR; Roman LJ; Lamont J; Masters BS; Bajaj M; Suraamornkul S; Belfort R; Berria R; Kellogg DL; Liu Y; DeFronzo RA J Clin Endocrinol Metab; 2005 Feb; 90(2):1100-5. PubMed ID: 15562034 [TBL] [Abstract][Full Text] [Related]
58. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022 [TBL] [Abstract][Full Text] [Related]
59. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019 [TBL] [Abstract][Full Text] [Related]
60. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]